1
/
of
0
FDA Drug Approval, N007883, ANTABUSE
FDA Drug Approval, N007883, ANTABUSE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 007883
Company: TEVA WOMENS
Drug Name: ANTABUSE
Active Ingredients: DISULFIRAM
Strength: 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: TABLET;ORAL
Action Date: 08/28/1951
Marketing Status: Discontinued
Submission Classification: Type 1 - New Molecular Entity
Company: TEVA WOMENS
Drug Name: ANTABUSE
Active Ingredients: DISULFIRAM
Strength: 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: TABLET;ORAL
Action Date: 08/28/1951
Marketing Status: Discontinued
Submission Classification: Type 1 - New Molecular Entity
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details